HYFT MindWalk Holdings, Inc.: Market Capitalization

Official company branding of MindWalk Therapeutics (HYFT)

This price chart for MindWalk Holdings (HYFT) reflects the price action of an asset whose risks are tied to the early stages of AI algorithm implementation and a dependence on investments at the 0.05 level. Management is focused on the digitalization of antibody synthesis to accelerate therapy. The business relies on the B2B precision medicine segment, utilizing neural networks for protein modeling and the treatment of orphan diseases.

HYFT (MindWalk Holdings Inc.) Market Value history from 09/05/2025 to 11/16/2026

Comprehensive metric breakdowns and analytics for MindWalk Holdings (HYFT)

- stock price and consensus target price:
Fundamental company analysis:HYFT (MindWalk)
Product sample of MindWalk Therapeutics

Market capitalization is calculated as the product of the current share price and the total number of outstanding shares. This indicator reflects the aggregate market value of the business and its investment attractiveness. For MindWalk Holdings (HYFT), this volume confirms the capitalization of intellectual potential within the field of AI algorithms for biopharmaceuticals. Growth in the company's market capitalization signals confidence in the efficiency of its R&D resources. Analyzing the price action of this market capitalization helps avoid buying at local peaks.

Key competitors

Market Value Haleon Group HLN|Kenvue Inc. - Market Value|VRNA - Market Value|MENS (jyongbio.com) - Market Capitalization|LGND: Market Capitalization|Market Capitalization AMRX|Market Value Perrigo|Alvotech Corp - Market Valuation|Market Capitalization LQDA|GLPG (Galapagos NV) - Market Value|Market Capitalization ANIP (anipharmaceuticals.com)|Market Capitalization MannKind Corp MNKD|AMPH - Market Value|Market Value PCRX (Pacira Corp)|ars-pharma.com (SPRY) - Market Value|Market Valuation Theravance Biopharma|AQST (aquestive.com) - Market Capitalization|Market Capitalization scPharmaceuticals|Market Valuation TECX (Tectonic Therapeutic Inc.)|TNXP (Tonix Pharmaceuticals Holding) - Market Value|Market Value China SXT Pharmaceuticals, Inc. SXTC|eupraxiapharma.com (EPRX) - Market Value|BHST: Market Valuation|eXoZymes - Market Value|ORMP: Market Capitalization|Entera Bio Ltd - Market Value|ABVC (ABVC BioPharma Inc.) - Market Capitalization|Market Value cumberlandpharma.com CPIX|Market Value Quantum BioPharma (QNTM)|FGEN (FibroGen) - Market Value|Telomir Pharmaceuticals, Inc. - Market Valuation|Market Value RANI|SNYR: Market Valuation|RLYB - Market Capitalization|LEXX (Lexaria Bioscience) - Market Valuation|PULM (Pulmatrix Inc) - Market Value|Market Valuation PTHL|APM: Market Value|Market Valuation LYRA (Lyra Therapeutics, Inc.)|Market Value IBO|Market Capitalization TNFA (TNF Pharmaceuticals)|Market Value YCBD|PainReform - Market Capitalization|Market Value CYTO (altamiratherapeutics.com)|LIPO (Lipella Pharmaceuticals) - Market Valuation|Market Value OptiNose (OPTN)|PIRS (Pieris Pharmaceuticals, Inc.) - Market Capitalization|PROC - Market Capitalization|Market Capitalization PTPI|QLI - Market Value|Market Value ACELYRIN SLRN|TFFP - Market Valuation